Anti-parasitic drug discovery takes a giant leap forward. | J Lipid Res;60(5): 919-921, 2019 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Anti-parasitic drug discovery takes a giant leap forward.

Nickels, Joseph T.

Affiliation

Nickels JT; Institute of Metabolic Disorders, Genesis Biotechnology Group, Hamilton, NJ 08691, and Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University, New Brunswick, NJ 08901. Electronic address: jnickels@venenumbiodesign.com.

J Lipid Res ; 60(5): 919-921, 2019 05.

Article in En | MEDLINE | ID: mdl-30918064

Subject(s)

Acanthamoeba; Drug Discovery; Anti-Bacterial Agents; Antimetabolites; Phylogeny

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acanthamoeba / Drug Discovery Language: En Journal: J Lipid Res Year: 2019 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acanthamoeba / Drug Discovery Language: En Journal: J Lipid Res Year: 2019 Document type: Article